epr spectroscopy

Bruker BioSpin Group, headquartered in Zurich, has acquired the electron paramagnetic resonance business of Bridge12, a Massachusetts-based company known for enabling cutting-edge research using EPR technology. The deal adds to Bruker’s suite of EPR spectroscopy offerings. Meanwhile, Bridge12 plans to focus on developing high power gyrotrons for commercial fusion reactors, and to continue its developments in nuclear magnetic resonance. […]